ACTIVE

EURO PHARMA

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result-36,4 k €+88,8 %over 1 year
Gross margin17,8 k €+107,5 %over 1 year
Equity-435,1 k €-9,1 %over 1 year

Identity

Source · BCE/KBO

EURO PHARMA is a Private limited company incorporated in 2022. Its registered office is in Grâce-Hollogne.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0784.494.230
Incorporation
05/04/2022
Legal form
Private limited company
Registered office
Rue Sélys Longchamps(Jean de) 27
4460 Grâce-Hollogne · WallonieSee on map
Contributed capital
5 000,00 €
Latest accounts
30/06/2025
Signals
Positive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin17,8 k €-235,9 k €-69,6 k €
EBITDA17,5 k €-287,6 k €-70,9 k €
Operating result-26,3 k €-312,7 k €-78,9 k €
Net result-36,4 k €-324,2 k €-79,5 k €
Balance sheet
Equity-435,1 k €-398,7 k €-74,5 k €
Total assets219,6 k €191,5 k €355,2 k €
Cash547,4 €1 k €42,8 k €
Debts654,7 k €590,1 k €429,7 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Marc SMETS

Director · since 01 avril 2022

Active

Ended mandates

Marc SMETS

Managing director · since 01 avril 2022

Ended

Full financial information

Source · NBB
202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202305/04/2022
Closing of the financial year30/06/202530/06/202430/06/2023
Length of the financial year12 months12 months15 months
Filing date30/01/202618/02/202505/01/2024
General meeting03/11/202504/11/202403/11/2023
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202503/11/202530/01/2026FrenchPDF
Micro model30/06/202404/11/202418/02/2025FrenchPDF
Micro model30/06/202303/11/202305/01/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Marc SMETS

Director · since 01 avril 2022

Active

Ended mandates

Marc SMETS

Managing director · since 01 avril 2022

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other07/04/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-36,4 k €↑
  2. 2024
    Annual accounts 2024-324,2 k €↓
  3. 2024
    Name changeEURO PHARMA LUIK
  4. 2023
    Annual accounts 2023-79,5 k €
  5. 2023
    Name changeEURO PHARMA
  6. 05/04/2022
    IncorporationPrivate limited company